Investigating the molecular mechanism of P-gp/NHERF-1 network at feto maternal interface and role of paracrine signaling of EVs containing drug transporter proteins
Investigating the molecular mechanism of P-gp/NHERF-1 network at feto maternal interface and role of paracrine signaling of EVs containing drug transporter proteins
批准号:
10748250
负责人:
Ananth kumar Kammala
金额:
$35.64万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2026-05-31
关键词:
ABCG2 geneBindingBinding ProteinsBiological AssayBispecific Antibody 2B1Carrier ProteinsCategoriesCell surfaceCellsChorionClinicalCompensationComplementDLG4 geneDataDeciduaDecidua BasalisDecidual CellDevicesDiseaseDown-RegulationDrug Delivery SystemsDrug DesignDrug EffluxDrug KineticsDrug RegulationsDrug TransportDrug resistanceDyesEnvironmentEvaluationExposure toFamilyFetal MembranesFetusGene SilencingGlycoproteinsHumanHydrogenImageIndividualInflammationInflammatoryInflammatory ResponseInterventionKineticsKnockout MiceKnowledgeLabelLipopolysaccharidesMaternal-Fetal ExchangeMicroscopyModelingMolecularMothersMusNutrientOATP TransportersOrganOrgan ModelOxidative StressParacrine CommunicationPathologicPathway interactionsPatientsPermeabilityPharmaceutical PreparationsPharmacotherapyPlacentaPregnancyPregnancy OutcomeProteinsRegulationRiskRisk FactorsRoleSignal InductionSmall Interfering RNASodiumStainsTacrolimusTechnologyTeratogensTestingTimeTissuesTransportationWestern Blottingadverse pregnancy outcomecigarette smokecytotrophoblastdecidua parietalisdrug mechanismextracellular vesiclesfetalfetus cellimprovedin uteroin vitro Modelin vivo Modelinhibitorinnovationinsightknock-downlipophilicitylive cell imagingmicrophysiology systemmyometriumneonatal outcomenovelorgan on a chipparticlepregnantprotein functionresponsesodium-hydrogen exchanger regulatory factorsolutetranscriptometrophoblastuptake
中文摘要
摘要
妊娠期药物治疗是不可避免的,目前的干预策略并不成功
降低妊娠相关疾病的风险。更好地了解药物的转运机制
胎儿-母体接口(FMI)的参与是改善妊娠和新生儿结局所必需的。这个
药物转运蛋白的表达水平随着妊娠期的进展而降低。我们的数据
提示钠氢交换调节因子-1(NHERF-1)与外排转运蛋白相互作用
蛋白质,通透性糖蛋白(P-gp),这种相互作用主要在胎膜中更多
而不是胎盘。与此数据相一致的是,外排药物机制在绒毛膜细胞中也较高。
胎盘滋养层细胞多于胎膜。另一方面,细胞外小泡来自于胎儿
膜参与旁分泌信号,引起母体蜕膜和
子宫肌层。此外,EV携带药物转运蛋白作为它们的货运蛋白,并参与
修饰母体细胞以进行转运蛋白功能活动。这项建议建立在这些观察的基础上;
核心假设是胎膜中的NHERF-1可能是调节药物的靶点
怀孕期间的交通工具。我们将确定P-gp/NHERF-1在胎儿体内的机制网络
母体接口使用创新的FM-解放军-片上器官(OOC)器件(AIM-1)。在目标1中,我们将使用
OOC模拟宫内环境以测试P-gp底物他克莫司在FMI中的动力学
正常的健康和疾病状况,以及NHERF-1的存在和不存在。的表达方式
P-gp和NHERF-1将通过FMI确定。来源于胎膜的EVS携带药物
转运蛋白,但它们在药物转运调节中的作用尚不清楚。在AIM-2中,我们将
探讨母体细胞摄取EVS的机制并确定其在药物调控中的作用
运输使用P-gp击倒小鼠。鉴于NHERF-1和来自胎儿的EVS的关键作用
膜调控药物转运具有重要的科学意义和临床意义。成功者
这项研究的完成将为了解胎膜TPS和EVS是如何在FMI中产生的提供新的见解
在妊娠期间超越胎盘界限的药物药代动力学中发挥作用,并将有助于
设计药物输送策略以治疗不良妊娠结局。
英文摘要
ABSTRACT
Pharmacotherapy during pregnancy is inevitable and current interventional strategies are not successful in
reducing the risks of pregnancy related disorders. A better understanding of the drug transport mechanisms
involved at feto-maternal interface (FMi) is required to improve the pregnancy and neonatal outcomes. The
expression levels of the drug transporter proteins decrease as the gestation period progresses. Our data
suggested that sodium hydrogen exchange regulatory factor-1 (NHERF-1) interacts with efflux transporter
protein, permeability glycoprotein (P-gp), and this interaction is predominantly more in the fetal membrane
rather than the placenta. Consistent with this data, efflux drug mechanism is also higher in the chorion cells of
fetal membrane than placenta trophoblast cells. On the other hand, extracellular vesicles derived from fetal
membrane are involved in the paracrine signaling that induce inflammatory changes in maternal decidua and
myometrium. Along with that, EVs carry drug transporter proteins as their cargo proteins and are involved in
modifying maternal cells for transporter protein functional activities. This proposal builds on these observations;
the central hypothesis is the NHERF-1 in the fetal membrane could be targeted to regulate the drug
transportation during pregnancy. We will determine the mechanistic network of P-gp/NHERF-1 across fetal
maternal interface using innovative FM-PLA - organ on chip (OOC) devices (Aim-1). In Aim 1, we will use the
OOC that mimic an in-utero environment to test the kinetics of P-gp substrate, Tacrolimus across the FMi in
normal healthy and disease conditions along with in presence and absence of NHERF-1. The expression of
the P-gp and NHERF-1 will be determined across the FMi. EVs derived from the fetal membrane carry drug
transporter proteins but their role in the regulation of drug transportation remains unknown. In Aim-2 we will
explore the uptake mechanism of the EVs by maternal cells and determine their role in regulating drug
transportation using P-gp knock down mice. Given the critical role of NHERF-1 and EVs from the fetal
membrane regulates the drug transportation is of significant scientific and clinical importance. The successful
completion of the study will provide novel insights into how the fetal membrane TPs and EVs derived at FMi
have a role in drug pharmacokinetics during pregnancy beyond the boundaries of the placenta and will help to
design drug delivery strategies to treat adverse pregnancy outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing IL-10 encapsulated exosomes as novel therapeutics for spontaneous preterm birth
-
批准号:10592047
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2022
-
负责人:Ananth kumar Kammala
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: